A Killorglin father says the HSE’s decision to approve reimbursement for a gene therapy drug will change his son’s life.Five-month-old Theo Whelan has been diag.
The price of a life-changing drug for Irish babies with a rare progressive disease has been agreed. The HSE will now reimburse single-dose Zolgensma gene .